Platelets and thrombin generation

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 22, Issue 9, 2002, Pages 1381-1389

  Monroe, Dougald M ^a   Hoffman, Maureane ^b   Roberts, Harold R ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coagulation; Lipids; Phosphatidylserine; Platelets; Thrombin

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 5A; FIBRIN; FIBRINOGEN; LIPID; PHOSPHATIDYLSERINE; PROTHROMBIN; THROMBIN;

ANIMAL CELL; BLOOD CLOTTING; FIBRIN FORMATION; HEMOSTASIS; HUMAN; HUMAN CELL; LIPID COMPOSITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTHROMBIN TIME; REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTE MEMBRANE; THROMBOGENESIS;

ANIMALS; BLOOD PLATELETS; HUMANS; MODELS, BIOLOGICAL; THROMBIN;

EID: 0036739889     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000031340.68494.34     Document Type: Review

References (118)

1. Ueber einen neuen formbestandtheil des blutes und dessen rolle bei der thrombose und der blutgerinnung
2. Sur le mécanisme de l'arrêt des hémorrhagies
3. Untersuchungen über thrombose: Bildung der thromben
4. Studies on blood coagulation, IV: The nature of the clotting deficiency in hemophilia
5. A study of the coagulation defect of hemophilia and in jaundice
6. Effect of blood platelets on prothrombin utilization of dog and human plasmas
7. A brain extract as a substitute for platelet suspensions in the thromboplastin generation test
8. The partial thromboplastin time with kaolin
9. Factor Va-factor Xa interaction: Effects of phospholipid vesicles of varying composition
10. Membrane phospholipids are the major determinant of the binding site for factor X activating- and prothrombinase complexes at the surface of human platelets
11. Reconstitution of phospholipid scramblase activity from human blood platelets
12. Procoagulant expression in platelets and defects leading to clinical disorders
13. Development of procoagulant binding sites on the platelet surface
14. The nature of the binding for prothrombinase at the platelet surface as revealed by lipolytic enzymes
15. Waterfall sequence for intrinsic blood clotting
16. An enzyme cascade in the blood clotting mechanism, and its function as a biological amplifier
17. Heredity and coagulation studies in ten families with factor XI (plasma thromboplastin antecedent)
18. The enigma of severe factor XI deficiency without haemorrhagic symptoms
19. Factor XI deficiency and its management
20. 2+ and phospholipids to the activation of human blood-coagulation factor X by activated factor IX
21. Prothrombinase complex assembly: Kinetic mechanism of enzyme assembly on phospholipid vesicles
22. 2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII
23. Use of annexin-V to demonstrate the role of phosphatidylserine exposure in the maintenance of haemostatic balance by endothelial cells
24. Comparison of the coagulant activities of platelets and phospholipids
25. Properties of the factor Xa binding site on human platelets
26. On the existence of platelet receptors for factor V(a) and factor VIII(a)
27. Active site-inactivated factors VIIa, Xa, and IXa inhibit individual steps in a cell-based model of tissue factor-initiated coagulation
28. A cell based model of hemostasis
29. Platelet procoagulant complex assembly in a tissue factor-initiated system
30. Transmission of a procoagulant signal from tissue factor-bearing cell to platelets
31. Mechanism of factor VIIa-dependent coagulation in hemophilia blood
32. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor
33. A journey with platelet P-selectin: The molecular basis of granule secretion, signalling and cell adhesion
34. Platelets, leukocytes, and coagulation
35. Tissue factor accelerates the activation of coagulation factor VII: The role of a bifunctional coagulation cofactor
36. Activation of human factor VII by factors IXa and Xa on human bladder carcinoma cells
37. Hepsin, a putative membrane-associated serine protease, activates human factor VII and initiates a pathway of blood coagulation on the cell surface leading to thrombin formation
38. Activation of human factor V by factor Xa and thrombin
39. Human coagulation factor V is activated to the functional cofactor by elastase and cathepsin G expressed at the monocyte surface
40. Functional prothrombinase complex assembly on isolated monocytes and lymphocytes
41. Partial purification and characterization of extrinsic pathway inhibitor (the factor Xa-dependent plasma inhibitor of factor VIIa/tissue factor)
42. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: Insight into its possible mechanism of action
43. Platelet adhesion receptors and (patho)physiological thrombus formation
44. Platelet interaction with collagen fibrils in flowing blood, I: Reaction of human platelets with alpha chymotrypsin-digested subendothelium
45. Surface expression and functional characterization of alpha-granule factor V in human platelets: Effects of ionophore A23187, thrombin, collagen, and convulxin
46. The isolation of human platelet factor V
47. In situ-generated thrombin is the only enzyme that effectively activates factor VIII and factor V in thromboplastin-activated plasma
48. Thrombin activates factor XI on activated platelets in the absence of factor XII
49. Thrombin-mediated feedback activation of factor XI on the activated platelet surface is preferred over contact activation by factor XIIa or factor XIa
50. Factor X bound to the surface of activated human platelets is preferentially activated by platelet-bound factor IXa
51. Prothrombinase is protected from inactivation by tissue factor pathway inhibitor: Competition between prothrombin and inhibitor
52. Prothrombin protects factor Xa in the prothrombinase complex from inhibition by the heparin-antithrombin complex
53. Morphology of the hemostatic plug in human skin wounds: Transformation of the plug
54. The haemostatic plug in haemophilia A: A morphological study of haemostatic plug formation in bleeding time skin wounds of patients with severe haemophilia A
55. A detailed morphological evaluation of the evolution of the haemostatic plug in normal, factor VII and factor VIII deficient dogs
56. Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation
57. Selective outside-inside translocation of aminophospholipids in human platelets
58. Exposure of endogenous phosphatidylserine at the outer surface of stimulated platelets is reversed by restoration of aminophospholipid translocase activity
59. Platelet activation and blood coagulation
60. Isolated deficiency of platelet procoagulant activity
61. Impaired factor X and prothrombin activation associated with decreased phospholipid exposure in platelets from a patient with a bleeding disorder
62. A hereditary bleeding disorder of dogs caused by a lack of platelet procoagulant activity
63. Metal binding sites of a gamma-carboxyglutamic acid-rich fragment of bovine prothrombin
64. Soluble phospholipids enhance factor Xa-catalyzed prothrombin activation in solution
65. Soluble phosphatidylserine binds to a single identified site in the C2 domain of human factor Va
66. Role of procoagulant lipids in human prothrombin activation, 2: Soluble phosphatidylserine upregulates and directs factor X(a) to appropriate peptide bonds in prothrombin
67. Localization of phosphatidylserine binding sites to structural domains of factor Xa
68. Role of procoagulant lipids in human prothrombin activation, 1: Prothrombin activation by factor X(a) in the absence of factor V(a) and in the absence and presence of membranes
69. Variability in platelet procoagulant activity in healthy volunteers
70. Structural and functional mapping of the thrombin domain involved in the binding to the platelet glycoprotein Ib
71. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation
72. Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity
73. Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of Par-1 on intact platelets
74. Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib
75. The platelet high affinity binding site for thrombin mimics hirudin, modulates thrombin-induced platelet activation, and is distinct from the glycoprotein Ib-IX-V complex
76. The role of platelet von Willebrand factor in the binding of factor VIII to activated platelets
77. Modulation of thrombin-mediated activation of factor VIII:C by calcium ions, phospholipid, and platelets
78. Fibrin-dependent platelet procoagulant activity requires GPIb receptors and von Willebrand factor
79. Binding of coagulation factor XI to washed human platelets
80. Identification and characterization of a binding site for platelets in the Apple 3 domain of coagulation factor XI
81. Factor XI binding to activated platelets is mediated by residues R(250), K(255), F(260), and Q(263) within the apple 3 domain
82. Prothrombin is a cofactor for the binding of factor XI to the platelet surface and for platelet-mediated factor XI activation by thrombin
83. Factor XI binding to the platelet glycoprotein Ib-IX-V complex promotes factor XI activation by thrombin
84. The role of phospholipids and factor Va in the prothrombinase complex
85. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane: Studies in Scott syndrome: An isolated defect in platelet procoagulant activity
86. Interaction of coagulation factor V and factor Va with platelets
87. Deficiency of factor Xa-factor Va binding sites on the platelets of a patient with a bleeding disorder
88. Platelet factor Xa receptor
89. The contribution of bovine factor V and factor Va to the activity of prothrombinase
90. Contribution of platelet-derived factor Va to thrombin generation on immobilized collagen- and fibrinogen-adherent platelets
91. Effector cell protease receptor-1, a platelet activation-dependent membrane protein, regulates prothrombinase-catalyzed thrombin generation
92. The elusive factor Xa receptor: Failure to detect transcripts that correspond to the published sequence of EPR-1
93. Comparative interactions of factor IX and factor IXa with human platelets
94. Coagulation factor IXa binding to activated platelets and platelet-derived microparticles: A flow cytometric study
95. Comparison of lipid binding and kinetic properties of normal, variant, and gamma-carboxyglutamic acid modified human factor IX and factor IXa
96. Role of gamma-carboxyglutamic acid residues in the binding of factor IXa to platelets and in factor-X activation
97. Platelet activity of high-dose factor VIIa is independent of tissue factor
98. Platelet-derived microparticles express high affinity receptors for factor VIII
99. The binding of 35S-labeled recombinant factor VIII to activated and unactivated human platelets
100. Structural and functional characterization of platelet receptor-mediated factor VIII binding
101. Specificity of phosphatidylserine-containing membrane binding sites for factor VIII: Studies with model membranes supported by glass microspheres (lipospheres)
102. Specific membrane binding of factor VIII is mediated by O-phospho-L-serine, a moiety of phosphatidylserine
103. Reconstitution of the purified platelet fibrinogen receptor: Fibrinogen binding properties of the glycoprotein IIb-IIIa complex
104. Human platelets possess an inducible and saturable receptor specific for fibrinogen
105. Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface
106. Exposure of platelet fibrinogen receptors by ADP and epinephrine
107. A point mutation in the integrin beta 3 cytoplasmic domain (S752→P) impairs bidirectional signaling through alpha IIb beta 3 (platelet glycoprotein IIb-IIIa)
108. The effect of fibrin clots and clot-bound thrombin on the development of platelet procoagulant activity
109. Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody: Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis"
110. Inhibition of platelet-dependent prothrombinase activity and thrombin generation by glycoprotein IIb/IIIa receptor-directed antagonists: Potential contributing mechanism of benefit in acute coronary syndromes
111. Antiplatelet agents in tissue factor-induced blood coagulation
112. Networking in the hemostatic system: Integrin alphaiibbeta3 binds prothrombin and influences its activation
113. Oral anticoagulation thresholds
114. Interdonor variability of platelet response to thrombin receptor activation: Influence of P1A2 polymorphism
115. Contribution of erythrocytes to thrombin generation in whole blood
116. Platelet regulation of thrombin generation in cardiovascular disease
117. Thrombin generation in newborn plasma is critically dependent on the concentration of prothrombin
118. "Normal" thrombin generation